These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 4043871)

  • 61. [Effects of cadralazine on the respiration, circulation, kidney, autonomic nervous system, digestive system, blood and so on].
    Nishimori T; Nishimura T; Kobayashi F; Nakano D; Fukuda Y; Sakonjyo H; Nakanishi J; Kimura A; Tsuji H; Higashio T
    Nihon Yakurigaku Zasshi; 1988 Apr; 91(4):221-36. PubMed ID: 3391446
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Cardiovascular effects of MY-5116 and MY-1250].
    Horii D; Hara Y; Hanazuka M; Nishi H
    Nihon Yakurigaku Zasshi; 1986 Apr; 87(4):417-26. PubMed ID: 3087848
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Pharmacodynamics of 2-(4-benzyl-piperidino)-1-(4-hydroxyphenyl)-1-propanol (Ifenprodil). (3) Effects on the autonomic, peripheral and central nervous systems].
    Mizusawa H; Yamane M; Sakai K
    Nihon Yakurigaku Zasshi; 1976 Mar; 72(2):185-99. PubMed ID: 987966
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Pharmacokinetics of the two major metabolites of ethyl loflazepate (CM6912) in dogs and humans. Simulation by a digital computer].
    Ito M; Aizawa K; Komiya I; Miyagi K; Fujita M; Umemura K
    Yakugaku Zasshi; 1986 Aug; 106(8):703-8. PubMed ID: 3806367
    [No Abstract]   [Full Text] [Related]  

  • 65. Pharmacological profile of the new antidepressant levoprotiline.
    Noguchi S; Okada M; Inukai T
    Arzneimittelforschung; 1992 Jun; 42(6):787-94. PubMed ID: 1418032
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Effects of dihydroergotamine mesylate (DEM) on the cardiovascular and nervous systems (author's transl)].
    Fukawa K; Honda H; Kubota H; Hatanaka Y; Sawabe T
    Nihon Yakurigaku Zasshi; 1982 Mar; 79(3):225-36. PubMed ID: 7084820
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Effects of guanabenz on the cardiovascular system, in comparison with clonidine and guanethidine].
    Hojo M; Yoshida Y; Nagasaka Y; Machida K; Tatsumi H
    Nihon Yakurigaku Zasshi; 1983 Jan; 81(1):39-58. PubMed ID: 6852681
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Characterization of the muscarinic receptor subtype(s) mediating contraction of the guinea-pig lung strip and inhibition of acetylcholine release in the guinea-pig trachea with the selective muscarinic receptor antagonist tripitramine.
    Roffel AF; Davids JH; Elzinga CR; Wolf D; Zaagsma J; Kilbinger H
    Br J Pharmacol; 1997 Sep; 122(1):133-41. PubMed ID: 9298539
    [TBL] [Abstract][Full Text] [Related]  

  • 69. General pharmacology of cis-malonato[4R,5R)-4,5-bis-(aminomethyl)-2-isopropyl-1,3- dioxolane]platinum(II).
    Kim DK; Ahn JS; Ryu G; Kim KH; Park CW; Kim MS; Chung MH; Shin SG; Suh YH; Kim YS
    Arzneimittelforschung; 1994 Sep; 44(9):1080-8. PubMed ID: 7986249
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effects of endothelin on the cardiovascular system and on smooth muscle preparations in different species.
    Lembeck F; Decrinis M; Pertl C; Amann R; Donnerer J
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Dec; 340(6 Pt 2):744-51. PubMed ID: 2699356
    [TBL] [Abstract][Full Text] [Related]  

  • 71. General pharmacology of the new non-xanthine adenosine A1 receptor antagonist (+)-(R)-[(E)-3-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)acryloyl]-2- piperidine ethanol.
    Terai T; Kusunoki T; Kita Y; Yoshida K; Akahane A; Shiokawa Y; Kohno Y; Horiai H; Mori J; Mine Y; Kohsaka M
    Arzneimittelforschung; 1996 Feb; 46(2):185-91. PubMed ID: 8720311
    [TBL] [Abstract][Full Text] [Related]  

  • 72. General pharmacological properties of the new angiotensin II receptor antagonist (+/-)-1-(cyclohexyloxycarbonyloxy) ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl) biphenyl-4-yl] methyl]-1 H-benzimidazole-7-carboxylate. Part II: Effect on cardiovascular system and renal functions.
    Kito G; Ito K; Shiomi M
    Arzneimittelforschung; 1996 Jul; 46(7):681-6. PubMed ID: 8842337
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Pharmacological studies on new cephamycin, MT-141. (1) Its effect on central nervous system, respiration and cardiovascular system].
    Kurebe M; Asaoka H; Yamaki Y; Sugiyama S; Shibasaki Y; Nishimori T; Kobayashi F
    Jpn J Antibiot; 1984 Jul; 37(7):1428-39. PubMed ID: 6436555
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Behavioral effects of ethyl loflazepate and its metabolites].
    Ueki S; Watanabe S; Yamamoto T; Shibata S; Shibata K; Ohta H; Ikeda K; Kiyota Y; Sato Y
    Nihon Yakurigaku Zasshi; 1983 Nov; 82(5):395-409. PubMed ID: 6142848
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effects of brovincamine on the autonomic nervous function in the dog and rat.
    Kushiku K; Abe M; Katsuragi T; Furukawa T
    J Pharmacobiodyn; 1984 Mar; 7(3):177-85. PubMed ID: 6086870
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Evidence for adrenergic and tachykinin activity in venom of the stonefish (Synanceja trachynis).
    Hopkins BJ; Hodgson WC; Sutherland SK
    Toxicon; 1996 May; 34(5):541-54. PubMed ID: 8783449
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Sedative-hypnotic properties of a new benzodiazepine in comparison with flurazepam. Pharmacological and clinical findings.
    Babbini M; Torrielli MV; Strumia E; Gaiardi M; Bartoletti M; De Marchi F
    Arzneimittelforschung; 1975 Aug; 25(8):1294-1300. PubMed ID: 241364
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part I: Respiratory and cardiovascular systems.
    Hirohashi M; Takasuna K; Yamashita N; Tamura K
    Arzneimittelforschung; 1991 Jan; 41(1):9-18. PubMed ID: 1675573
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Pharmacological studies of 2-(5H-[1]benzopyrano[2,3-b]pyridin-7-yl) propionic acid (Y-8004) (II). General pharmacological action].
    Maruyama Y; Kadobe Y; Imamura H
    Nihon Yakurigaku Zasshi; 1976 May; 72(4):403-16. PubMed ID: 987973
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part II: Central and peripheral nervous systems.
    Hirohashi M; Takasuna K; Kasai Y; Usui C; Kojima H
    Arzneimittelforschung; 1991 Jan; 41(1):19-24. PubMed ID: 1675569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.